Slide Decks on Depression
Depression is a broad and heterogeneous diagnosis. The many symptoms of depression cause clinically significant distress or impairment in social, occupational, or other important areas of functioning. The severity of the disorder is determined by both the number and severity of symptoms, as well as the degree of functional impairment.
Major Depressive Disorder (MDD) often has a remitting and relapsing course, and symptoms may persist between episodes. Where possible, the key goal of an intervention should be complete relief of symptoms (remission), which is associated with better functioning and a lower likelihood of relapse. Clinical guidelines recommend several approaches to the treatment of MDD: Pharmacotherapy (e.g., antidepressants), which can include combination therapy of more than one medication. Psychological therapy (e.g., cognitive–behavioral therapy) can be given alongside pharmacotherapy.
Our educational slide decks are designed to include a comprehensive range of subjects, from the definition of MDD to its global prevalence, its comorbidities, prognosis, and treatment options. All our materials are developed by experts in the field and are available for free download and use in your presentations.

Definitions and Diagnosis
This slide deck explains fundamental concepts and definitions related to depression, including signs and symptoms, differential diagnosis, and commonly used screening and rating instruments. Go to the slide deck.

Epidemiology and Burden
This slide deck presents the essential components of the epidemiology and burden of Major Depressive Disorder (MDD), summarizing global patterns and societal impacts. Go to the slide deck.

Neurobiology and Aetiology
This slide deck introduces the neurobiology and aetiology of major depressive disorder (MDD), focusing on the genetic, biological, environmental, and psychological factors that shape its development. Go to the slide deck.

Course, Natural History and Prognosis
Major depressive disorder (MDD) is characterized by discrete episodes of changes in affect, cognition, and neurovegetative functions. Depression often has a remitting and relapsing course. Go to the slide deck.

Comorbidity
The various comorbidities of Major Depressive Disorder (MDD) negatively impact patients’ quality of life. This slide deck discusses in detail the presence of comorbidity in MDD. Go to the slide deck.

Treatment Principles
This slide deck includes comprehensive slides and figures illustrating the treatment principles of Major Depressive Disorder (MDD), such as pharmacotherapy and non-pharmacological therapies. Go to the slide deck.
Articles on Depression
Depression is a clinically heterogeneous disorder. The many symptoms of depression are varied, and can include emotional, cognitive, and physical symptoms that cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
Read and download our articles, written by experts, which introduce the latest advances in research in depression and the future clinical practice related to Major Depressive Disorder (MDD).
Watch the Videos on Depression
MDD is most frequently characterized by relapses and recurrences. The symptoms of depression may persist between episodes. The various symptoms of depression have a negative impact on many aspects of the patient’s life. Listen to our experts discuss diverse topics in depression research, uncovering different aspects of this clinically heterogeneous disorder.

Polygenic Scores in Psychiatry
Dr. Jasmina Mallet explains the latest research in psychiatric genetics, emphasizing the role of Polygenic Risk Scores (PRS) in psychiatry.

Diagnostic challenges in Bipolar Disorder and Depression
In this video, Professors Lakshmi Yatham, MD., and Christoph Correll, MD. discuss the challenges of differentiating bipolar depression, unipolar depression, depression with mixed features, schizophrenia, and schizoaffective disorder.

The Heterogeneity of Depression
In this video, Professor Dr. Brenda Penninx discusses the heterogeneity of major depressive disorder, with specific reference to immunometabolic depression.
Download Illustrations & Figures on Depression
Explore our comprehensive library of downloadable illustrations, designed to improve your understanding of scientific and medical concepts and enhance your presentations. We have numerous illustrations and explanations on topics such as Noradrenergic and Specific Serotonergic Antidepressants, the Effects of a Noradrenaline Antagonist, Specific Noradrenaline Re-Uptake Inhibitors, and much more.
Frequently Asked Questions (FAQ)
The information provided in this document is for educational purposes only and is not a substitute for medical care. If you have questions about your health, speak with a healthcare professional.
Depression, also known as depressive disorder, is a mental health condition involving a prolonged period of low mood or a loss of interest or pleasure in activities. Major depressive disorder, the most recognised form of depression, is marked by distinct episodes lasting at least two weeks and often longer. These episodes involve significant changes in mood, sleep, appetite, interest, physical activity, cognition, and functioning, with periods of remission between them.
References
- WHO. Depressive disorder (depression). Accessed January 16, 2026. https://www.who.int/news-room/fact-sheets/detail/depression
- Diagnostic and Statistical Manual of Mental Disorders | Psychiatry Online. DSM Library. Accessed January 16, 2026. https://www.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
Depression is a complex condition with no single cause. It often results from a combination of genetic, biological, environmental, and psychological factors. For some individuals, a family history of depression may increase their risk. Imbalances in brain chemicals, such as neurotransmitters like serotonin and dopamine, can underlie symptoms of depression. Stressful life events, such as trauma or significant life changes, can trigger depression, especially in people who are already predisposed or vulnerable.
References
Depression is common, affecting around 5% of adults worldwide, or about 280 million people. By the age of 75, the chances of developing depression at some point in life are estimated to be 20% for men and 34% for women.
References
- WHO. Depressive disorder (depression). Accessed January 16, 2026. https://www.who.int/news-room/fact-sheets/detail/depression
- McGrath JJ, Al-Hamzawi A, Alonso J, et al. Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries. Lancet Psychiatry. 2023;10(9):668-681. doi:10.1016/S2215-0366(23)00193-1
Common symptoms of depression include persistent feelings of sadness, emptiness, or irritability, often accompanied by physical and cognitive changes that significantly impair an individual’s ability to function. These symptoms are more intense and longer-lasting than everyday mood changes and can seriously disrupt daily life. People with severe depression may experience suicidal thoughts and may make attempts to harm themselves. The functional impact of major depressive disorder often stems directly from its individual symptoms. For example, feeling constantly exhausted can make it difficult to get out of bed or go to work, while feelings of hopelessness might cause a person to withdraw from family and friends. In some cases, the impairment may be mild enough that those around the affected person may not notice the depressive symptoms. However, the degree of impairment can vary significantly. In severe cases, individuals may be completely unable to perform basic self-care tasks or may become mute or catatonic. People with major depressive disorder who seek treatment in general medical settings often experience higher levels of physical pain, illness, and significant reductions in their ability to function physically, socially, and in daily responsibilities.
References
- Diagnostic and Statistical Manual of Mental Disorders | Psychiatry Online. DSM Library. Accessed January 16, 2026. https://www.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
- Depression – National Institute of Mental Health (NIMH). Accessed November 25, 2024. https://www.nimh.nih.gov/health/publications/depression
Depression is diagnosed by a healthcare professional, such as a general practitioner or a psychiatrist, based on a thorough clinical evaluation. This evaluation often includes a discussion of symptoms, medical history, and sometimes a physical examination to rule out other conditions. The diagnosis is typically guided by the criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) or the International Classification of Diseases (ICD-11), which outlines specific symptoms and the necessary duration for diagnosing major depressive disorder.
References
- Diagnostic and Statistical Manual of Mental Disorders | Psychiatry Online. DSM Library. Accessed January 16, 2026. https://www.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
- Depression – National Institute of Mental Health (NIMH). Accessed November 25, 2024. https://www.nimh.nih.gov/health/publications/depression
Effective care for depression often includes psychotherapy, medication, or a combination of both. If these approaches do not significantly alleviate symptoms, neurostimulation therapies may be considered as alternative treatment options.
Medications:
Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin–norepinephrine reuptake inhibitors (SNRIs), help treat depression by influencing brain chemicals involved in mood regulation, including serotonin and norepinephrine. These medications may take several weeks to show effects and can cause side effects such as nausea, headaches, and sleep disturbances, which often improve over time. In some cases, antidepressants may increase the risk of suicidal thoughts in the short term, particularly in young people, making close monitoring important during the early stages of treatment.
Psychotherapy:
Psychological treatments, including cognitive-behavioural therapy (CBT) and other therapeutic approaches, can help individuals identify and change unhelpful thought patterns and behaviours that contribute to depressive symptoms.
Other treatments:
In cases of severe or treatment-resistant depression, medication combinations with or without psychotherapy and brain stimulation therapies are options that might be helpful. Brain stimulation therapies include electroconvulsive therapy (ECT), a highly effective option typically used when conventional treatments have proven ineffective, and transcranial magnetic stimulation (TMS), a less invasive approach. Vagus Nerve stimulation is also useful in some patients with chronic treatment resistant depression.
Depression is highly treatable, and many people make a full recovery. However, for some individuals, depression may be recurrent or chronic and require long-term management. The overall goal of treatment is to reduce symptoms and support people in leading fulfilling lives, even if occasional episodes occur.
References
- WHO. Depressive disorder (depression). Accessed January 16, 2026. https://www.who.int/news-room/fact-sheets/detail/depression
- Diagnostic and Statistical Manual of Mental Disorders | Psychiatry Online. DSM Library. Accessed January 16, 2026. https://www.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
- Depression – National Institute of Mental Health (NIMH). Accessed November 25, 2024. https://www.nimh.nih.gov/health/publications/depression
- IQWiG. Depression: Learn More – How effective are antidepressants? In: InformedHealth.Org [Internet]. Institute for Quality and Efficiency in Health Care (IQWiG); 2024. Accessed January 16, 2026. https://www.ncbi.nlm.nih.gov/books/NBK361016/
Positive lifestyle changes can be crucial for managing depression. Staying connected with friends and family, keeping up with enjoyable activities, exercising regularly, and maintaining healthy eating and sleeping habits can all promote wellbeing. Alcohol and drugs can worsen symptoms and should be avoided. Speaking with a trusted person and seeking support from a healthcare professional are essential.
References
- Antidepressants: Medications used to treat depression by balancing chemicals in the brain that affect mood and emotions.
- CBT (Cognitive Behavioural Therapy): Therapy that targets unhelpful thoughts and behaviours to reduce distress and improve functioning.
- Dopamine: A neurotransmitter in the brain that plays a key role in how we feel pleasure and motivation.
- Diagnostic and Statistical Manual of Mental Disorders (DSM-5): A manual used by healthcare professionals to diagnose mental health conditions, including depression.
- ECT (Electroconvulsive Therapy): A treatment for severe depression that involves sending small electric currents through the brain to trigger a brief seizure, often helping to improve symptoms.
- ICD-11 (International Classification of Diseases, Eleventh Revision): A global standard for diagnosing health conditions and diseases, maintained by the World Health Organization.
- Neurotransmitters: Chemicals in the brain that transmit signals between nerve cells, affecting mood, emotions, and behaviour.
- Norepinephrine: A neurotransmitter that helps regulate mood, alertness, and stress response.
- Psychotherapy: Talk therapy that helps people understand and manage their mental health issues by talking with a therapist.
- Serotonin: A neurotransmitter that affects mood, sleep, and appetite. Low levels of serotonin are linked to depression.
- SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors): A type of antidepressant that increases levels of both serotonin and norepinephrine in the brain.
- SSRIs (Selective Serotonin Reuptake Inhibitors): A type of antidepressant that increases serotonin levels in the brain, commonly used to treat depression.
- TMS (Transcranial Magnetic Stimulation): A non-invasive treatment for depression that uses magnetic fields to stimulate nerve cells in the brain.
References
- WHO. Depressive disorder (depression). Accessed January 16, 2026. https://www.who.int/news-room/fact-sheets/detail/depression
- Diagnostic and Statistical Manual of Mental Disorders | Psychiatry Online. DSM Library. Accessed January 16, 2026. https://www.psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
- Depression – National Institute of Mental Health (NIMH). Accessed November 25, 2024. https://www.nimh.nih.gov/health/publications/depression
- APA Dictionary of Psychology. Accessed January 16, 2026. https://dictionary.apa.org/
3D Brain Atlas
In the 3D Brain Atlas you can see many of the brain’s structures from a 360 degree viewpoint, make various sagittal incisions through the brain, read more about the structures, and download images of the brain that you can use in your own presentations.
Some areas of the brain appear to be particularly associated with depression. Biological factors contributing to depression, especially in terms of brain structure and function, include:
- Hippocampal atrophy
- Thinner cortical grey matter in the orbitofrontal cortex, anterior and posterior cingulate and insula
- Overactivation of the amygdala under emotional exposure








